Latest Posts & Updates

A new federally funded study into the effects of cannabis terpenes suggests that the compounds could be “potential therapeutics for chronic neuropathic pain,” finding that an injected dose of the compounds produced a “roughly equal” reduction in pain markers when compared to a smaller dose of morphine. Terpenes also appeared to enhance the efficacy of morphine when given in combination.

Americans consider marijuana to be significantly less dangerous than cigarettes, alcohol and opioids—and they say cannabis is less addictive than each of those substances, as well as technology—according to a new poll. The survey, released by the American Psychiatric Association (APA) and Morning Consult last week, looked at public opinion on the dangers and addictiveness of six different substances, plus technology.

The Food and Drug Administration (FDA) and Federal Trade Commission (FTC) have teamed up to send warning letters to six companies that the agencies say are unlawfully selling “copycat” delta-8 THC products that are misleadingly packaged to mimic popular brands like Doritos, Cheetos and Jolly Ranchers.

When it comes to purchasing marijuana, many people focus solely on the THC percentage. This can lead to the belief that the higher the THC percentage, the better the experience. However, this is not necessarily true.

As technology and science around cannabis advances, new cannabinoids are entering the marketplace. Research is pinpointing what these compounds are capable of and the results are encouraging.

A new study to be completed by researchers in the United Kingdom will explore how cannabis affects the human brain.